CALVIN SANDRA (VP, Corp Controller and CAO) sold 6.0% of their position (2.91K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $104.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/16/2025ACC: 0001882909-25-000006
Officer· VP, Corp Controller and CAO
Since Sep 2021
-2.91K
Net shares
Net seller
$104.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.91K
Price / share
$36.00
Trade value
$104.76K
% of position
6.0%
12/15/2025
48.55K→45.63K
Total
Net shares
−2.91K
Net value
-$104.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | S · Sale | −2.91K | $36.00 | $104.76K | 6.0% | 48.55K | 45.63K |
| Total | −2.91K | -$104.76K | ||||||
Derivative Transactions0
No derivative transactions reported